The global biopharmaceutical CMO & CRO market is expected to grow with the CAGR of 8% by 2025

According to a new market report published by Lucintel, the future of the biopharmaceutical CMO (Contract Manufacturing Organization) & CRO (Contract Research Organization) market looks promising with opportunities in the pharmaceutical, biotechnological and medical device industries. The global biopharmaceutical CMO & CRO market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are increasing demand for biologics, rising biopharmaceutical industry, and time and cost saving benefits offered to biopharmaceutical companies by contract services.
Biopharmaceutical CMO & CRO are organizations providing comprehensive services to pharmaceutical biotechnology, and medical device industry. In this market, biologics and biosimilars are the major products. Lucintel forecasts that biologics will remain the largest segment over the forecast period due to complex manufacturing steps, high specificity of biologics, and a higher success rate as compared to other drug molecules.
Within this market, mammalian will remain the largest segment by source over the forecast period due to their capabilities of adding human-like post-translational modifications to complex protein therapeutics and new developments in this segment leading to more productive and efficient manufacturing of biologics using mammalian cells.
North America will remain the largest region over the forecast period due to presence of large number of small and mid-size biopharmaceutical entities (SMEs) that are lacking the resources and budget to establish facilities with well-equipped resources in the region.
Lonza, Rentschler Biotechnologie, Boehringer Ingelheim, JRS Pharma, Inno Biologics, ProBioGen, Fujifilm Diosynth Biotechnologies, Samsung BioLogics, and Toyobo are among the major suppliers in the global biopharmaceutical CMO & CRO market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global biopharmaceutical CMO & CRO market by product, service, source, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Biopharmaceutical CMO & CRO Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global biopharmaceutical CMO & CRO market by product, service, source, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:

• Biologics
  • Monoclonal Antibodies (MAbs)
  • Recombinant Proteins
  • Vaccines
  • Antisense, RNAi (Ribonucleic Acid Interference), & Molecular Therapy
  • Others
• Biosimilars

By Service [Value ($ Million) shipment analysis for 2014 – 2025]:

• Contract Manufacturing
  • Process Development
    • Downstream
    • Upstream
  • Fill & Finish Operations
  • Analytical & QC (Quality Control) Studies
  • Packaging
• Contract Research
  • Oncology
  • Inflammation & Immunology
  • Cardiology
  • Neuroscience
  • Others

By Source [Value ($ Million) shipment analysis for 2014 – 2025]:

• Mammalian
• Non-mammalian

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

• North America

• United States
• Canada
• Mexico

• Europe

• United Kingdom
• Spain
• Germany
• France

• Asia Pacific

• China
• India
• Japan

• The Rest of the World

• Brazil

 
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.